From code to cures: Chai Discovery’s big AI bet
TechCrunch - 15-Dec-2025OpenAI-backed Chai raises $130M to accelerate drug and antibody design with AI
Join the club for FREE to access the whole archive and other member benefits.
A biotechnology company specializing in molecular diagnostic tools
Chai Discovery is a company that provides tools and platforms for scientific research, focusing on technologies that streamline and automate laboratory workflows. It specializes in creating molecular diagnostic tools and laboratory instruments, with a focus on real-time PCR devices and related software for scientific research and diagnostics. Chai Discovery has introduced Chai-1, a multi-modal AI model designed for molecular structure prediction, achieving state-of-the-art performance in drug discovery tasks. Chai-1 excels at predicting proteins, small molecules, DNA, RNA, and more, surpassing benchmarks like AlphaFold. It's available for free through a web interface, including commercial use, and the code is open for non-commercial applications. The model can predict structures without MSAs and enhance drug discovery with lab data integration, reflecting the company’s mission to transform biology into engineering.
Visit website: https://www.chaidiscovery.com/
Details last updated 24-Sep-2024
OpenAI-backed Chai raises $130M to accelerate drug and antibody design with AI
Biotech startup’s valuation soars as it advances de novo protein generation with AI models.
An AI model set to transform drug discovery through cutting-edge molecular predictions